In Reply Whether slower reading contributes to Scantron filling speed is difficult to establish unless the same children are assessed on both tasks, which as far as I know has not been tested. While filling Scantron forms requires motor actions that reading does not, visual scanning is required to identify the circled answers and locate the corresponding answer bubbles. This engages oculomotor and visual skills in common with reading (eg, saccades, 1,2 accommodation, near vision). Therefore, reading-associated factors may be associated with performance on both tasks. The Brief Report by Kelly et al 3 In the original manuscript sent to me for comment, Drs Kelly and Birch concluded the abstract by stating that children with abnormal binocular vision history may require academic accommodations. This was amended in the final version, but I had overlooked the change. I note however that the published report still states that their findings "may aid in developing new guidelines in academic accommodations," 3(p940) and that a previous editorial by Drs Kelly and Birch appears to support such academic policies. 5 Personally, I think academic accommodations can help children with substantial visual or visuomotor deficits, if these cannot be ameliorated by treatments. Before jumping to policy recommendations, we may also need to reconcile current findings with previous population-level evidence, which did not show definitive and substantial associations between amblyopia and academic success. 6 This may be because academic success is multifactorial, requiring more than just fast reading and Scantron filling. I thank Drs Kelly and Birch for providing this opportunity to clarify my comments. 
Implications of Birdshot-Like Uveitis on the Pathogenesis of Birdshot Chorioretinopathy
To the Editor The recent article by Acaba-Berrocal et al 1 presents a case of birdshot-like chorioretinopathy in a patient who was HLA-A29-negative and received treatment with a checkpointblockade agent for malignant melanoma. This case is of considerable interest with implications for the immunopathogenesis of birdshot chorioretinopathy (BCR). In most, if not all, patients with BCR, HLA-A29 is found; however, HLA-A29 only confers risk, in that most white individuals who are HLA-A29-positive do not develop BCR. Increased risk is also conferred by killer-cell immunoglobulinlike receptor genes and the HLA-B44 subtype that interacts with killer-cell immunoglobulin-like receptors, 2 suggesting the possibility of either an infectious or neoplastic trigger. We believe the inciting event may be the presence of skin cancers or precancerous lesions, which are highly prevalent in middleaged white individuals, the population in which BCR is almost exclusively found. There is also a rare association of BCR with ocular melanoma, further supporting a role for neoplasia inciting the disease. 3 In the case presented by AcabaBerrocal et al, 1 we propose that immune activation through release of inhibition of the programmed cell death protein 1 checkpoint pathway in a patient treated for cutaneous melanoma mimics the altered immune reactivity to neoplastic changes in the skin (whether manifest or microscopic) in a subset of individuals who are HLA-A29-positive and develop BCR. Cancer immunosurveillance could lead to initiation of BCR through antigenic mimicry involving presentation on HLA-A29 or loss of immunological tolerance. The situation is complex and multifactorial, as evidenced by the rarity of BCR even in middle-aged white people. For example, isolation of viral DNA from nonmelanoma skin cancers and their premalignant precursors suggests the potential of additional antigenic stimulation from highly immunogenic viral epitopes in a system adapted toward suppression of herpes-class viruses. 4 While it has been suggested that patients with BCR may have a higher incidence of skin cancers, this association has not been well established. However, in some individuals, the inciting cancers may be successfully suppressed or eliminated by the mobilized immune system, resulting secondarily in the development of BCR in an autoimmunity-promoting milieu, without manifestation of clinically diagnosed skin cancer. This is congruent with recent observations that with cancer immunotherapy, the development of uveitis and vitiligo as adverse effects frequently signals successful tumor response.
In Reply We read with interest the letter from Sun et al regarding possible pathophysiologic implications of our article on birdshot-like chorioretinopathy associated with pembrolizumab treatment. 1 In the article, we observed a single patient who was treated for cutaneous melanoma with a checkpointinhibitor agent directed against the programmed cell death-1 receptor on T cells and soon thereafter developed a classicappearing case of birdshot chorioretinopathy (BCR) in both eyes. Testing for HLA-A29 was negative. We speculated that this immunotherapy was associated with the development of clinical features of BCR. Based on this case, Sun et al proposed a detailed theory that "immune surveillance and response to cutaneous neoplasia or ocular melanomas may contribute to the development of BCR." We were not aware of this association. Looking back over our 31 years of experience in a busy ocular oncology practice, which has involved treating several thousand patients with uveal melanoma, there has been no patient who clinically manifested BCR. Further, the association with cutaneous melanoma has not been verified. A PubMed search for "cutaneous melanoma and birdshot" yielded no reports. However, we agree with the authors that immune surveillance likely plays a role in BCR. In this case, the immunotherapy checkpoint inhibitor unleashed and activated T cells, which likely led to the development of this immunemediated condition. The exact cascade of events remains unknown, to our knowledge.
Although many of the uveitides remain idiopathic or undifferentiated, we should always strive to find the underlying cause or causes. For example, tattoo-associated uveitis is a rare form of uveitis with clinical features that can mimic sarcoidosis. Whether tattoo-associated uveitis represents a distinct entity or a subset of cutaneous sarcoidosis remains unclear. 2 It is possible that the morphology of some of the uveitides may represent a final common pathway in the ocular inflammatory cascade, so that similar clinical findings may have multiple causes, including genetic predispositions and environmental exposure.
Understanding of the pathophysiology of BCR is limited by the rarity of the disease, paucity of histopathologic specimens, inconsistent descriptions of findings, limited understanding of genetic factors, and sometimes conflicting case definitions. The association of BCR with melanoma, as described by Pulido et al, 3 and the hypothesis of Sun et al that immune surveillance and response to cutaneous neoplasia or ocular melanomas may contribute to the development of BCR (which helps to explain why BCR is almost always found in white individuals who are middle-aged and older, rather than others) represent tantalizing clues toward unraveling the mysteries of this disease. Perhaps big data, such as that of the American Academy of Ophthalmology's Intelligent Research in Sight registry and the French national registry for rare diseases, by using feature-based rather than diagnosis-based data sets, will provide confirmation of the hypothesis of Sun et al. 4, 5 We appreciate their interest in our findings and look forward to hearing more from their future research.
